Nonalcoholic Steatohepatitis with Advanced Fibrosis

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS trial_result · 2024-09-20
Clinical Trial Update: Hepatic Impairment, Cholestatic Liver Disease, & NASH with Advanced Fibrosis & Normal Hepatic Function [Phase 1]
Phase 1 trial by Zydus Therapeutics evaluating hepatic impairment, cholestatic liver disease, and nonalcoholic steatohepatitis with advanced…